China Research and Intelligence (CRI) has emerged to provide high-level research and advisory services to all those with keen interest in different Chinese markets and industries. The firm, founded in 2007, is headquartered in Shanghai, China. Their team’s principle goal is to present the most helpful and reliable insights and information, sincerely serving a broad choice of multinational and local customers with their business practice and ethics.
CRI’s reports are packed with precise analysis of key market indicators, strategic recommendations from industry experts, market estimated figures, projections, reviews of competitive strategies, consumers investigation, reviews of business models, market share analyses, key forces driving of restraining market growth.
CRI’s scope of offerings encircles numerous market research reports, industry analytical reviews, company business reports, industry-specific research databases. Further, the company also offers outsource and custom-tailored services for research organisations, and multiple report readers.
Publications found:
1,345
Sort by:
Investigation Report on China Ossotide Market, 2010-2019
US$ 2,000.00
... of rheumatoid arthritis (RA) is 0.2%-0.36% and the number of cases is 5-10 million in China. Apart from RA, osteoarthritis, an expression of ... ossotide in China competitive landscape of ossotide in Chinese market price of ossotide made by different enterprises in China market outlook of ossotide in China ...
June 2015
35 pages
Investigation Report on China Progesterone Market, 2010-2019
US$ 2,000.00
... progesterone in the Chinese market is imported and made by Fleet (UK) and Capsugel(FR). The rest mainly comes from such local manufacturers as Asen, Zhejiang Xianju Pharmaceutical Co., Ltd ... steroid drugs will keep growing and that with the development of downstream products, the demand for progesterone ...
June 2015
35 pages
Investigation Report on China Rosuvastatin Market, 2010-2019
US$ 2,000.00
... rosuvastatin (rosuvastatin calcium ... rosuvastatin in the Chinese market mainly come from the following companies: IPR Pharmaceuticals (US), Lunan Better Pharmaceutical Co., Ltd, Nanjing Chia Tai Tianqing, Simcere and Zhejiang Jingxin Pharmaceutical Co., Ltd, among which IPR Pharmaceuticals ...
June 2015
35 pages
Investigation Report on China Atorvastatin Market, 2010-2019
US$ 2,000.00
... in the near future. Atorvastatin, a common drug that can lower blood cholesterol levels, was developed by Pfizer under the trade name of Lipitor. Boasting of nearly ... miracle among all the medicines for sale. After entering China, atorvastatin develops fast with annual sales value rising from less ...
June 2015
30 pages
Investigation Report on China Tacrolimus Market, 2010-2019
US$ 2,000.00
... Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus ...
June 2015
30 pages
Investigation Report on China Insulin Lispro Market, 2010-2019
US$ 2,000.00
... : market size of insulin lispro in China market share of manufacturers of Insulin Lispro in China retail price of insulin lispro in Chinese market major manufacturers of insulin lispro in Chinese market market outlook of insulin lispro in China The author suggests ...
June 2015
20 pages
Investigation Report on China Capecitabine Market, 2010-2019
US$ 2,000.00
... name of Xeloda and then spread through over 80 countries and regions in 2 years. In Mar. 2001, capecitabine entered China to be clinically used for the treatment of advanced breast cancer, colorectal cancer and other solid tumors. The chemotherapy for colorectal cancer ...
June 2015
30 pages
Investigation Report on China Celecoxib Market, 2010-2019
US$ 2,000.00
... the market. In Sep. 2000, celebrex (celecoxib capsule) made by Pfizer Inc was approved by CFDA to enter China. Celecoxib develops fast then, ... celecoxib in Chinese market market outlook of celecoxib in China The author suggests the following groups of people purchase this report: manufacturers of NSAIDs ...
June 2015
20 pages
Investigation Report on China Desloratadine Market, 2010-2019
US$ 2,000.00
... desloratadine in China market share of manufacturers of desloratadine in China price of desloratadine in Chinese market major manufacturers of desloratadine in Chinese market market outlook of desloratadine in China ...
June 2015
30 pages
Investigation Report on China Doxofylline Market, 2010-2019
US$ 2,000.00
... doxofylline in China market share of manufacturers of doxofylline in China price of doxofylline in Chinese market major manufacturers of doxofylline in Chinese market market outlook of doxofylline in China ...
June 2015
30 pages
Investigation Report on China Ezetimibe Market, 2010-2019
US$ 2,000.00
... estimate of the incidence of hyperlipemia is 7%-8% while the actual incidence might be above 10%. Over 100 million people in China have to receive ... this report: market size of ezetimibe in China price of ezetimibe in Chinese market market outlook of ezetimibe in China The author suggests the following groups ...
June 2015
20 pages
Investigation Report on China Liraglutide Market, 2011-2019
US$ 2,000.00
... diabetes incidence in China. Liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, was developed by Novo Nordisk in 2008 to treat diabetes. Liraglutide, a derivative attained by attaching a fatty acid molecule to GLP-1 molecule, can reduce the HbA1c level and weight of type 2 diabetes ...
June 2015
25 pages
Investigation Report on China Methylprednisolone Market, 2010-2019
US$ 2,000.00
... varieties of steroid’s APIs, half are made in China. As a variety performing well in hospitals in recent years, methylprednisolone, ... methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn). The APIs and preparations of methylprednisolone ...
June 2015
30 pages
Investigation Report on China Octreotide Market, 2010-2019
US$ 2,000.00
... octreotide in China market share of manufacturers of octreotide in China price of octreotide in Chinese market major manufacturers of octreotide in Chinese market market outlook of octreotide in China ...
June 2015
30 pages
Investigation Report on China Recombinant Factor ? Market, 2010-2019
US$ 2,000.00
... and treatment of hemophilia have a huge market. Apart from Bayer Schering, Baxter and Wyeth also make recombinant factor Ⅷ too. After entering China, recombinant factor Ⅷ develops ... report: sales status of recombinant factor Ⅷ in China price of recombinant factor Ⅷ in Chinese market major manufacturers of recombinant factor Ⅷ in Chinese market share of dosage forms of recombinant factor Ⅷ in China market outlook of recombinant factor Ⅷ in China The author suggests ...
June 2015
30 pages
Investigation Report on China Tiotropium Bromide Market, 2010-2019
US$ 2,000.00
... tiotropium bromide in Chinese hospitals price of tiotropium bromide in Chinese hospitals major manufacturers of tiotropium bromide in Chinese market share of different dosage forms of tiotropium bromide in Chinese hospitals market outlook of tiotropium bromide in China ...
June 2015
20 pages
Investigation Report on China Olmesartan Market, 2010-2019
US$ 2,000.00
... hypertension is a controllable disease. In 1991, olmesartan medoxomil was successfully developed by Sankyo Pharmaceuticals Co., Ltd and was patented in many countries. In Apr. 2002, olmesartan medoxomil ... ARBs, olmesartan medoxomil has distinctive pharmacokinetic properties. It develops fast after entering China ...
June 2015
20 pages
Investigation Report on China Insulin Detemir Market, 2010-2019
US$ 2,000.00
... insulin detemir in Chinese market price of insulin detemir in Chinese market major manufacturers of insulin detemir in China share of different dosage forms of insulin detemir in Chinese market market outlook of insulin detemir in China ...
June 2015
20 pages
Investigation Report on China Linezolid Market, 2010-2019
US$ 2,000.00
... Linezolid, a synthetic oxazolidinone, was developed by Pharmacia & Upjohn. In 2000, it was approved by FDA to be used for infection caused by gram-positive ... China, linezolid market has long been monopolized by foreign pharmaceutical corporations. Since the patent for linezolid ...
June 2015
20 pages
Investigation Report on China Nifuratel Market, 2010-2019
US$ 2,000.00
... under the trade names of Macmiror and Macmiror Complex. Nifuratel develops fast after entering China with annual sales rising ... of nifuratel in Chinese market market outlook of nifuratel in China The author suggests the following groups of people purchase this report: manufacturers of gynecological ...
June 2015
30 pages
Investigation Report on China Oxiracetam Market, 2010-2019
US$ 2,000.00
... Senile dementia poses a serious threat to old people. According to statistics, about 10% of people aged above 60 suffer from senile dementia, among which 5% have Alzheimei’s Disease (AD). In China, the number of senile dementia ...
June 2015
30 pages
Investigation Report on China Phosphocreatine Market, 2010-2019
US$ 2,000.00
... market share compared with other cardiovascular drugs. According to CRI’s survey, phosphocreatine develops fast after entering China with annual sales value rising ... of phosphocreatine in Chinese market market outlook of phosphocreatine in China The author suggests the following groups of people purchase this report: manufacturers of drugs for cardiovascular disease investors ...
June 2015
30 pages
Investigation Report on China Rivaroxaban Market, 2010-2019
US$ 2,000.00
... After rivaroxaban entering the Chinese market under the trade name of Xarelto in the latter ... rivaroxaban in Chinese hospitals price of rivaroxaban in Chinese hospitals major manufacturers of rivaroxaban share of different dosage forms of rivaroxaban in Chinese hospitals market outlook of rivaroxaban in China ...
June 2015
20 pages
Investigation Report on China Tamsulosin Market, 2010-2019
US$ 2,000.00
... and prostate and reducing urethral pressure, but it can’t cure BPH. Compared with other α1-adrenergic receptor blockers, tamsulosin ... Boehringer Ingelheim. Prostate drug market is highly concentrated in China. Three kinds of prostate drugs – finasteride, tamsulosin and prostat which occupy over 90% of prostate ...
June 2015
30 pages
Investigation Report on China Voriconazole Market, 2010-2019
US$ 2,000.00
... fungal infection take up over 60%. Voriconazole, a kind of triazole, was developed by Pfizer and came into the US market in 2002. In 2005, voriconazole was introduced into China ... rest Chinese market. According to CRI’s investigation, Voriconazole develops fast after entering China with annual sales rising from ...
June 2015
30 pages
Investigation Report on China Montelukast Market, 2010-2019
US$ 2,000.00
... name of Singulair. In 2000 and 2002, Montelukast chewable tablets (4mg) and Montelukast granules ... China Montelukast’s price in Chinese hospitals the production status of generic drugs of Montelukast in China major Montelukast manufacturers and their market share in China Market outlook of Montelukast in China ...
May 2015
30 pages
Investigation Report on China Insulin Glargine Market, 2010-2019
US$ 2,000.00
... insulin glargine in China market share of insulin glargine manufacturers in sample hospitals in China retail price of insulin glargine in Chinese market major manufacturers of insulin glargine in Chinese market market outlook of insulin glargine in China ...
May 2015
30 pages
Investigation Report on China Rituximab Market, 2010-2019
US$ 2,000.00
... Rituximab in China Hospital Market Market Share of Rituximab by Dosage Form in China Hospital Market Incidence of Autoimmune Diseases in China Manufacturing Schedule of Rituximab Generic Drug Prospect of China Rituximab ...
May 2015
30 pages
Investigation Report on China Esomeprazole Market, 2010-2019
US$ 2,000.00
... Esomeprazole (Nexium) in China Hospital Market Major Esomeprazole Manufacturers in China Patent Status of Esomeprazole in China Share of Esomeprazole in Different Dosage Forms in China Hospital Market Prospect of China Esomeprazole ...
May 2015
30 pages
Investigation Report on China Acarbose Market, 2010-2019
US$ 2,000.00
... -2014 was about 13.7%. Currently, Bayer’s products have taken up 70% of Acarbose market in China while and Sichuan Luye Bao Guang Pharmaceutical Industry Co., Ltd claim the ... size of Acarbose in China major manufacturers of Acarbose for Chinese market and their market share retail price of Acarose in Chinese market market outlook of Acarbose in China The ...
May 2015
30 pages
Investigation Report on China Clotrimazole Market, 2010-2019
US$ 2,000.00
... valued. As clotrimazole is sold at a relatively low price, it grows fast despite a small market scale. Ever since its first entry into China, clotrimazole develops ... : market size of clotrimazole in China major manufacturers of clotrimazole in Chinese market and their market share retail price of clotrimazole in Chinese market market outlook of clotrimazole in China The author ...
May 2015
30 pages
Investigation Report on China Megestrol Market, 2010-2019
US$ 2,000.00
... use hormone therapy. Common varieties of progestin are medroxyprogesterone and megestrol which act by blocking the source of human estrogen with an unsatisfactory ... size of megestrol in China major manufacturers of megestrol for Chinese market and their market share retail price of megestrol in Chinese market market outlook of megestrol in China The author ...
May 2015
30 pages
Investigation Report on China Nicergoline Market, 2010-2019
US$ 2,000.00
... market size of nicergoline in sample hospitals was about CNY 89 million in 2010 and CNY 76 million in 2014. In future years, China's nicergoline market will shrank ... price of nicergoline in hospital market in China Market Share of Major Nicergoline Manufacturers in China Patent Status of Nicergoline in China Market share of Nicergoline by dosage form in hospital market in China Prospect of China Nicergoline Market The ...
May 2015
30 pages
Research report on China's industrial pump industry 2010-2019
US$ 2,200.00
... , made China’s technical level of pump for key use is approaching international standard. Main fields demand for pump in China’s market as below: Environment protection industry, water ... of pump in China will reach CNY 377.32 billion. COMPANIES MENTIONED Shanghai East Pump (Group) Co., Ltd Nanfang Pump Industry Co., Ltd. Leo Group Co., Ltd. SHIMGE PUMP GROUP ...
May 2015
60 pages
Research Report on Auto Glass Industry in China, 2011-2020
US$ 2,400.00
... China's automobile market has huge development potential. The annual growth rate of China’s auto glass market demand is expected to remain above 10% in 2016- 2020. Problems still exist in China’s auto glass ...
April 2015
60 pages
Research Report on Auto Glass Industry in China, 2014-2018
US$ 2,400.00
... market. The average automobile reserve was 100 per 1,000 people in China by the end of 2013. The global average level was 150 while ... has huge development potential as economy develops. The annual growth rate of China auto glass market is expected to remain above 15% in 2014-2018. However, problems still ...
June 2014
60 pages
Research Report on Photovoltaic (PV) Industry in China, 2014-2018
US$ 2,400.00
... for free within 45 days and purchase the surplus electric power of photovoltaic power generation projects with the price of 1 CNY/kWh, which ... Industry Import and Export of PV Forecast on Development of China Photovoltaic Industry The following enterprises and people are recommended to purchase this report ...
June 2014
50 pages
Research Report on Cement Industry in China, 2014-2018
US$ 2,400.00
... off power to restrict consumption at the end of 2010. Consequently, the demand of cement remarkably exceeded supply while the price hit a historical high in ... time due to low development degree, large development space and policy keynote in China. Cement industry will continue to benefit from the urbanization ...
May 2014
50 pages
Research Report on Environmental Protection Industry in China, 2014-2018
US$ 2,400.00
... number will exceed CNY 600 billion in 2017. The State Council of China put real estate as the mainstay industry in 2003. The CAGR ... Protection Enterprises and the Operation Status in China Prospect of Development of China Environmental Protection Industry The following enterprises and people are recommended ...
May 2014
50 pages
Research Report on Machine Tool Industry in China, 2014-2018
US$ 2,400.00
... solve the problems. Unlike the decline of import in 2009, the import of machine tools will not experience long-lasting and rapid growth ... and Trading Enterprises of Machine Tools Enterprises Related to Industry Chain of Machine Tools Investors/Research Institutes Concerned about China Machine Tool Industry ...
May 2014
50 pages
Research Report on Non-ferrous Metal Industry in China, 2014-2018
US$ 2,400.00
... will slightly increase and the prices will fluctuate at low level in China in 2014-2015. Industrial restructuring will be further deepened as the pressure of ... this report, the readers can acquire the following information: Government Policies of China Non-ferrous Metal Industry Supply and Demand Status of ...
May 2014
50 pages
Research Report on Industrial Robot Industry in China, 2014-2018
US$ 2,400.00
... the original countries though several international giants establish production bases in China. Therefore, industrial robots are technology-intensive products while the ... and low-end market while the high-end market of industrial robots will continue to be seized by international giant enterprises in the coming ...
May 2014
50 pages
